Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results. (Q44061913)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results. |
scientific article |
Statements
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results (English)
Hagop M Kantarjian
Stefan Faderl
2 references
Susan O'Brien
2 references
Mary Beth Rios
2 references
Guillermo Garcia-Manero
2 references
Michael Andreeff
Jorge E Cortes
2 references
Michael Keating
2 references
Maher Albitar
2 references
Jean-Pierre J Issa
Steven M Kornblau
Jenny Shan
Moshe Talpaz
Francis J Giles
Debra Resta
Renaud Capdeville
Terry L Smith
Deborah A Thomas
Charles Koller
Milosav Beran
Emil J Freireich